Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
    • Post-Market Surveillance
      • R-TF-007-001 Post-Market Surveillance (PMS) Plan
      • R-TF-007-002 Post-Market Clinical Follow-up (PMCF) Plan
      • R-TF-007-003 Periodic Safety Update Report (PSUR)
      • R-TF-007-005 Post-Market Clinical Follow-up (PMCF) report
      • deprecated
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Pricing
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Post-Market Surveillance

Post-Market Surveillance

📄️ R-TF-007-001 Post-Market Surveillance (PMS) Plan

Purpose

📄️ R-TF-007-002 Post-Market Clinical Follow-up (PMCF) Plan

Manufacturer contact details

📄️ R-TF-007-003 Periodic Safety Update Report (PSUR)

General information

📄️ R-TF-007-005 Post-Market Clinical Follow-up (PMCF) report

Details

🗃️ deprecated

1 item

Previous
R-TF-029-003 — Clinical Workflow and Operational Readiness Commissioning Record
Next
R-TF-007-001 Post-Market Surveillance (PMS) Plan
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)